White House says Biden has yet to make a decision about new FDA commissioner By Reuters

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

WASHINGTON (Reuters) – White House press secretary Jen Psaki said on Thursday that U.S. President Joe Biden has yet to make a final decision on who to nominate to lead the Food and Drug administration.

Multiple media reports have said Biden is focusing on former FDA commissioner Robert Califf, but Psaki said “not yet” when asked if the president has made a final decision.

“We are certainly eager to do this in short order,” Psaki noted.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.